Texas Yale Capital Corp. Merck & Co., Inc. Transaction History

Texas Yale Capital Corp.

$2.28 Billion
Q3 2024

A detailed history of Texas Yale Capital Corp. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Texas Yale Capital Corp. holds 39,938 shares of MRK stock, worth $3.84 Million. This represents 0.2% of its overall portfolio holdings.

Number of Shares

39,938

Previous 40,373 1.08%

Holding current value

$3.84 Million

Previous $5 Million 9.26%

% of portfolio

0.2%

Previous 0.24%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$111.15 - $128.97 $48,350 - $56,101	-435 Reduced 1.08%	39,938 $4.54 Million
Q2 2024 Aug 13, 2024	BUY	$123.8 - $132.96 $57,567 - $61,826	465 Added 1.17%	40,373 $5 Million
Q3 2023 Nov 09, 2023	SELL	$102.95 - $114.33 $20,590 - $22,866	-200 Reduced 0.5%	39,908 $4.11 Million
Q4 2022 Feb 13, 2023	SELL	$87.44 - $112.11 $201,112 - $257,853	-2,300 Reduced 5.42%	40,108 $4.45 Million
Q3 2022 Nov 08, 2022	BUY	$84.53 - $94.96 $87,488 - $98,283	1,035 Added 2.5%	42,408 $3.65 Million
Q2 2022 Aug 11, 2022	BUY	$83.49 - $94.64 $68,461 - $77,604	820 Added 2.02%	41,373 $3.77 Million
Q4 2021 Feb 10, 2022	BUY	$72.28 - $90.54 $53,631 - $67,180	742 Added 1.86%	40,553 $3.11 Million
Q3 2021 Nov 08, 2021	BUY	$71.68 - $78.83 $1,433 - $1,576	20 Added 0.05%	39,811 $2.99 Million
Q2 2021 Aug 05, 2021	BUY	$70.31 - $77.77 $23,975 - $26,519	341 Added 0.86%	39,791 $3.1 Million
Q1 2021 May 12, 2021	SELL	$68.86 - $81.11 $475,134 - $559,659	-6,900 Reduced 14.89%	39,450 $3.04 Million
Q4 2020 Feb 10, 2021	BUY	$71.77 - $79.65 $2,870 - $3,186	40 Added 0.09%	46,350 $3.79 Million
Q2 2020 Jul 31, 2020	SELL	$70.42 - $80.13 $34,294 - $39,023	-487 Reduced 1.04%	46,310 $3.58 Million
Q1 2020 May 13, 2020	BUY	$63.36 - $87.82 $495,538 - $686,840	7,821 Added 20.07%	46,797 $3.6 Million
Q4 2019 Feb 11, 2020	BUY	$77.58 - $87.54 $2,560 - $2,888	33 Added 0.08%	38,976 $3.55 Million
Q2 2019 Jul 24, 2019	SELL	$69.84 - $81.59 $2.61 Million - $3.05 Million	-37,335 Reduced 48.95%	38,943 $3.27 Million
Q1 2019 May 10, 2019	BUY	$69.58 - $79.36 $2.73 Million - $3.12 Million	39,274 Added 106.13%	76,278 $6.34 Million
Q4 2018 Feb 11, 2019	BUY	$65.24 - $75.71 $87,030 - $100,997	1,334 Added 3.74%	37,004 $2.83 Million
Q2 2018 Aug 07, 2018	SELL	$50.83 - $59.72 $78,176 - $91,849	-1,538 Reduced 4.13%	35,670 $2.17 Million
Q1 2018 May 03, 2018	BUY	$50.96 - $59.23 $86,632 - $100,691	1,700 Added 4.79%	37,208 $2.03 Million
Q4 2017 Feb 07, 2018	SELL	$51.62 - $61.64 $603,437 - $720,571	-11,690 Reduced 24.77%	35,508 $2 Million
Q3 2017 Nov 08, 2017	BUY	$58.67 - $63.13 $2.77 Million - $2.98 Million	47,198	47,198 $3.02 Million

Others Institutions Holding MRK

# of Institutions

3,820

Shares Held

1.87B

Call Options Held

15.6M

Put Options Held

13.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $244B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Yale Capital Corp., based on Form 13F filings with the SEC.

News

Stay updated on Texas Yale Capital Corp. with notifications on news.

Account

Texas Yale Capital Corp. Merck & Co., Inc. Transaction History